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Abstract
Inflammation involves in many cigarette smoke (CS) related diseases including the chronic obstructive pulmonary disease
(COPD). Lung epithelial cell released IL-8 plays a crucial role in CS induced lung inflammation. CS and cigarette smoke
extracts (CSE) both induce IL-8 secretion and subsequently, IL-8 recruits inflammatory cells into the lung parenchyma.
However, the molecular and cellular mechanisms by which CSE triggers IL-8 release remain not completely understood. In
this study, we identified a novel extracellular matrix (ECM) molecule, CCN1, which mediated CSE induced IL-8 secretion by
lung epithelial cells. We first found that CS and CSE up-regulated CCN1 expression and secretion in lung epithelial cells
in vivo and in vitro. CSE up-regulated CCN1 via induction of reactive oxygen spices (ROS) and endoplasmic reticulum (ER)
stress. p38 MAPK and JNK activation were also found to mediate the signal pathways in CSE induced CCN1. CCN1 was
secreted into ECM via Golgi and membrane channel receptor aquaporin4. After CSE exposure, elevated ECM CCN1
functioned via an autocrine or paracrine manner. Importantly, CCN1 activated Wnt pathway receptor LRP6, subsequently
stimulated Wnt pathway component Dvl2 and triggered beta-catenin translocation from cell membrane to cytosol and
nucleus. Treatment of Wnt pathway inhibitor suppressed CCN1 induced IL-8 secretion from lung epithelial cells. Taken
together, CSE increased CCN1 expression and secretion in lung epithelial cells via induction of ROS and ER stress. Increased
ECM CCN1 resulted in augmented IL-8 release through the activation of Wnt pathway.
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Introduction
Cigarette smoke (CS) is well known for its association with many
respiratory diseases including asthma, emphysema and lung
cancer [1,2]. Exposure to CS leads to the activation of an
inflammatory cascade in the upper and lower airway epithelium.
In bronchoalveolar lavage fluids (BALF) from smokers, elevated
neutrophils, eosinophils and macrophages are found [3,4]. The
accumulation of these inflammatory cells is thought to occur after
the release of chemotactic factors from lung epithelial cells in
response to CS [5]. Infiltration of inflammatory cells is associated
the consequent lung injury and remodeling involved in chronic
obstructive pulmonary diseases (COPD) [5]. Therefore, it is
important to understand the pathogenesis underlying the CS
induced lung inflammation. Airway epithelial cells are known to
secrete a variety of pro-inflammatory cytokines and chemokines
[6]. For instance, high concentrations of IL-8 have been detected
from the induced sputum or BALF obtained from patients with a
variety of respiratory conditions, including many CS related
diseases, such as chronic obstructive pulmonary diseases (COPD)
and chronic airway disease [7,8].
IL-8 (also named as neutrophil chemotactic factor) belongs to
the C-X-C chemokine family and plays a critical role in CS
induced respiratory disease [9]. It is not only a neutrophil
chemotactic factor, but also a potent activator for T-lymphocytes,
eosinophils, basophils and monocytes [10]. CS and cigarette
smoke extracts (CSE) both induce the release of IL-8, demon-
strated in cultured bronchial epithelial cells in vitro and in BALF
from smokers in vivo [9]. It is well accepted by many pulmonol-
ogists that CS triggers an inflammatory response by promoting
bronchial epithelial cells to release IL-8 [9]. Despite that CS/CSE
induced IL-8 from lung epithelial cells has been first demonstrated
more than a decade ago, the precise molecular mechanisms and
pathways involved in this event remain unclear. Better knowledge
on how CS/CSE triggers IL-8 release potentially provides novel
therapeutic targets for CS associated lung inflammation.
CCN1, also named Cyr61, belongs to the CCN protein family
(Cyr61, CTGF and Nov) [11]. CCN1 is a cysteine-rich, 38 kD
secreted protein which is expressed in a broad range of cells
including lung epithelial cells [12,13]. As an early stress response
gene product and an ECM protein, it plays critical functions in
tissue remodeling and repair, including the regulation of apoptosis,
differentiation, migration and proliferation [14]. Secreted CCN1
functions in a paracrine and/or autocrine manner (14). It interacts
with the integrin family, tyrosine kinase receptor type 1 (TRKA),
Wnt and Notch family receptor, to activate the intracellular
signaling pathway [11]. A marked induction of CCN1 is detected
in gene microarray studies using human tissue from patients with
cigarette smoke induced COPD/emphysema [15]. However, the
precise biological function of CCN1 in the setting of cigarette
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smoke exposure and its role in the smoke associated lung
inflammation remain unexplored.
Our current study identified that CCN1 plays a crucial role in
the process of CSE induced IL-8 release from airway epithelial
cells. This finding potentially provides a novel target for therapy
and biomarker development on CSE associated lung inflamma-
tion.
Materials and Methods
Human Lung Tissue
All human lung tissues, as previously reported, were obtained
from Lung Tissue Research Consortium. The severity of COPD
was classified following the guidelines of the Global Initiative for
Obstructive Lung Disease (GOLD) [16].
Animal
Male 6–8-week old C57BL/6 mice were purchased from
Jackson Laboratory (Bar Harbor, ME) and housed under
pathogen-free conditions at the animal facility at the Brigham
and Women’s Hospital (BWH). All animal experiment protocols
were approved by the Harvard Standing Committee for Animal
Welfare.
In vivo CS exposure. Mice were exposed to CS (100
cigarettes/day for 5 days/wk) for a total of 3 months using a
total body CS exposure chamber as described [17] [18]. Total
body CS exposure was performed in a stainless-steel chamber
(71 cm6 61 cm6 61 cm) using a smoking machine (model TE-
10; Teague Enterprises). The smoking machine puffs each 3R4F
cigarette for 2 s, for a total of nine puffs before ejection, at a flow
rate of 1.05 l/min, providing a standard puff of 35 cm3. The
smoke machine was adjusted to deliver 10 cigarettes at one time.
The chamber atmosphere was periodically measured for total
particulate matter and concentrations ranged from 100 to
120 mg/m3 (16).
Cell culture and treatment. Human bronchial epithelial
cell line Beas2B cells were purchased from American Type Tissue
Culture Collection (Manassas, VA). Beas2B cells were cultured in
Figure 1. CCN1 expression and secretion after cigarette smoking (CS) and cigarette smoking extracts (CSE). (A) IHC staining for CCN1
expression in human lung tissue obtained from non-smoker (right upper panel), patients in category GOLD 2 (left lower panel) and GOLD 4 (right
lower panel) Brown: positive CCN1 (black arrow). (B) CCN1 mRNA transcription after CS in mouse lung tissue. Mice were exposed to CS. After 2 weeks,
RNA was isolated from lung tissue and real time PCR was performed. CCN1 mRNA transcription was normalized by b-actin. (C) Mouse lung tissue
stained for CCN1 using Immunofluorescence (IF) in the presence and absence of cigarette smoking (3 months), Red arrow: positive CCN1. *p,.05
compared to sham. All figures above represented three independent experiments with similar results.
doi:10.1371/journal.pone.0068199.g001
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100-mm dishes, containing DMEM with 10%FBS (Life sciences,
Grand Island, NY), 2 nM L-glutamine, 100 mg/ml penicillin and
100 U/ml streptomycin, in humidified incubator under 5% CO2
at 37uC. Cells were exposed to 10% CSE in all the experiments.
For inhibitor treatment, inhibitors were pre-treated 1–3 h followed
by CSE exposure.
Isolation of Type II lung epithelial cells. The primary
alveolar type II (ATII) cells of mouse lung were obtained as
previously described [19]. In brief, mice were anaesthetized and
the lungs were perfused with cold PBS. Dispase solution (2 ml;
Gibco, Grand Island, NY) and 1% low-melting agarose (1 ml;
Invitrogen, Grand Island, NY) were infused into tracheal catheter.
The lungs were removed and transferred to 2 ml of dispase and
incubated on the shaker for 45 min at RT. The lung tissue was
teased and filtered through 100 mm and 20 mm strainers, and the
pellet was centrifuged. After suspending the cell pellets, the cells
were incubated on anti-CD 16/32 plus anti-CD45 pre-coated
plates for 1 h at 37uC. The unbounded cells were collected and
moved to non-coated plates for 4 h at 37uC, and then the
suspending cells were moved to fibronectin (Sigma-aldrich)-coated
plates. Three days later, CSE was treated for 24 h.
Preparation of cigarette smoke extraction (CSE). CSE
derived from Kentucky Reference 3R4F research blend cigarettes
(University of Kentucky) were prepared as described [17]. In brief,
CSE was prepared by bubbling smoke from 1 cigarette into 10 ml
serum-free DMEM medium and CSE was sterile-filtered through
a 0.2 mm filter (VWR International, Radnor, PA).
Chemicals and recombinant protein. NAC, ascorbic acid,
GSH, brefeldin A, tetraethylammonium chloride (TEA), a18-
glycyrrhetinic acid (GA), daidzein, 2-bromopalmitate (2-BP),
TGN-020, thapsigargin, 4-Phenylbutyric acid (4-PBA), bay 11-
7082 were purchased from Sigma-aldrich (St. Louis, MO),
tauroursodeoxycholic acid (TUDCA) from EMDMillipore (Merck
KGaA, Darmstadt, Germany), salubrinal from Santa Cruz
Biotechnology, JNK inhibitor, SB 203580, c-secretase inhibitor
from Calbiochem (Merck KGaA, Darmstadt, Germany), GSK
PERK inhibitor from Toronto Research Chemicals (Toronto,
Ontario, Canada). Recombinant human & anti-human CCN1
proteins were purchased from R&D systems (Minneapolis, MN).
Figure 2. CSE induced CCN1 secretion in lung epithelial cells. (A) CCN1 secretion induced by CSE (1,20%). Beas2B cells were treated with
CSE in a dose-dependent manner. After 24 h, CCN1 level in the cell supernatant was detected using ELISA. (B) Mouse lung primary type II epithelial
cells were exposed to CSE (10 or 20%). After 24 h, CCN1 in cell supernatant was detected as above. (C) Beas2B cells were treated with 10% CSE. After
6 h, ROS was detected using the carboxyl-H2DCFDA methods. (D) CSE induced CCN1 secretion was blocked by anti-oxidant reagents. Beas2B cells
were pre-treated with three different anti-oxidant reagents (NAC, ascorbic acid and GSH, 1 mM respectively), followed by 10% CSE. After 24 h, cell
supernatant was collected and CCN1 was detected as above. (E) CSE induced CCN1 release was inhibited by ER-Golgi secretion inhibitor, Brefeldin A
(BFA), in a dose-dependent manner. Beas2B cells were treated with BFA, followed by CSE. After 24 h, CCN1 secretion was detected using ELISA. (F)
Suppression of CSE induced CCN1 secretion by membrane channel protein inhibitors. Beas2B cells were treated with tetraethylammonium chloride
(TEA, 100 mM) for aquaporin 1, a18-glycyrrhetinic acid (GA, 100 mM) for connexin, daidzein (50 mM) for caveolin, 2-bromopalmitate (2-BP, 100 mM) for
palmitoylation, TGN-020(100 mM) for aquaporin 4. Then these cells were exposed to CSE. After 24 h, CCN1 secretion was determined. For all the
above, supernatant from the same amount of cells was collected and subjected to ELSIA. *p,.05 All figures above represented three independent
experiments with similar results.
doi:10.1371/journal.pone.0068199.g002
CCN1 Regulates IL-8 Release
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e68199
ELISA. Human CCN1 duoset ELISA was purchased from
R&D systems (Minneapolis, MN) and human IL-8 ELISA from
Thermo (Rockford, IL), mouse CCN1 ELISA kit from MyBio-
Source (San Diego, CA) and followed manufacturer’s instruction.
Western blot. Cells were harvested after twice cold PBS
washing and then suspended in RIPPA buffer with protease
inhibitors (Roche, Indianapolis, IN). Total protein samples were
resolved by 4–12% NuPAGE gel (Invitrogen, Carlsbad, CA ) and
transferred to PVDF membranes (Bio-Rad, Hercules, CA).
Membranes were blocked in 5% nonfat milk in PBST for 1 hour
at room temperature and then blocked with primary antibodies at
4uC overnight. CCN1 and b-actin antibody were purchased from
Santa Cruz (Santa Cruz, CA) and JNK, p-38 MAPK, pJNK, p-
p38 MAPK, Ire-1a, p-eIF2a, pLRP6, LPR6, Dvl2, Dvl3, b-
catenin, axin, PDI, ERp44, ERp94 and BiP/GRP78 from Cell
Signaling (Danvers, MA). Membranes were washed and incubated
with appropriate secondary antibodies (Santa Cruz, CA). Detec-
tion was performed using the SuperSignal West Pico and Femto
system (Pierce, IL) and exposed to Molecular ImagerH chemi
DocTM XRS+ (Bio-Rad, Hercules, CA). Normalization and
relative quantification were performed with Image Lab software
((Bio-Rad, Hercules, CA).
Small interfering RNA (siRNA) transfection. Human Ire-
1a siRNA was purchased from Ambion (Life Technologies, Grand
Island, NY), human JNK siRNA and p38 MAPK siRNA from
Cell Signaling (Danvers, MA) and INTERFERinH from Polyplus
(Illkirch, FRANCE). Transfection procedure was performed per
INTERFERinH manufacturer’s instruction.
Immunohistochemistry (IHC) & Immunofluorescence
(IF). Human lung tissues were fixed with 4% paraformaldehyde
and analyzed by immunohistochemical staining for anti-CCN1
(Santa Cruz Biotechnology, Santa Cruz, CA). Briefly, fixed,
paraffin-embedded lung tissue sections were deparaffinized with
xylene, rehydrated gradually with graded alcohol solutions, and
then washed with deionized water. Sections were retrieved by
Target Retrieval Solution (Dako). After incubation with 0.3%
H2O2 in methanol for 30 min, sections were blocked with
blocking serum from Vectastain Elite ABC Kit (Vector Labora-
tories) for 1 h. Next, the slides were incubated with anti-CCN1
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at 4uC
overnight, followed by incubating with biotinylated universal
antibodies for 30 min. Sections were then incubated with
Vectastain Elite ABC Reagent for 30 min at room temperature.
DAB substrate solution of Peroxidase Substrate Kit (Vector
Figure 3. CSE augmented CCN1 secretion via induction of ER stress. (A) CSE up-regulated ER stress markers in a time-dependent manner in
Beas2B cells. 10% CSE was used to treat Beas2B cells. After 24 h, cell lysate was subjected to Western Blot analysis. (B) CSE-induced BiP/GRP78
expression was suppressed by pre-treatment of 1 mM anti-oxidant, NAC, ascorbic acid and GSH, respectively. (C) Deletion of ER stress marker protein
BiP suppressed CSE induced CCN1 secretion. Beas2B cells were transfected with BiP siRNA or control siRNA (WT). Cells were then exposed to CSE
(10%). CCN1 secretion was determined as above. (D) Induction of CCN1 secretion by thapsigargin, an ER stress inducer, in a time and dose-dependent
manner. Beas2B cells were treated with thapsigargin. CCN1 secretion was determined as above. (E) Inhibition of CSE or thapsigargin induced CCN1
secretion by ER stress inhibitors, tauroursodeoxycholic acid (TUDCA, 10 mM), 4-phenylbutyric acid (4-PBA, 5 mM) and salubrinal (100 mM). Beas2B
cells were treated with these ER stress inhibitors followed by 10% CSE. CCN1 secretion was measured as above. (E) Suppression of CCN1 secretion by
membrane channel protein inhibitors. Beas2B cells were treated with each inhibitor, followed by ER stress inducer thapsigargin (1 mM). CCN1
secretion was measured as above. *p,.05 All figures above represented two or three independent experiments with similar results.
doi:10.1371/journal.pone.0068199.g003
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Laboratories) was applied to the sections and counterstained with
Hematoxylin QS (Vector Laboratories). After washing with
deionized water, sections were dehydrated gradually with graded
alcohol solutions and immersed in xylene. Slide sections were
mounted with Permount Mounting Medium (Fisher Scientific) and
covered with cover glass. For IF staining, formalin-fixed, paraffin-
embedded lung tissue sections were subject to IF staining with
anti-CCN1 and b-catenin as described previously [17]. Samples
Figure 4. ER stress induced CCN1 secretion via Ire-1, MAPK, JNK pathways in lung epithelial cells. (A) CSE (10%)-induced CCN1 secretion
in the presence of the inhibitors for ER stress related signaling. Beas2B cells were treated with JNK inhibitor II (10 mM), SB203580 (10 mM) for P38
MAPK, Bay11-7082 (10 mM) for NF-kB, GSK PERK (1 mM) for PERK and c-secretase inhibitor (10 mM). Next, cells were exposed to CSE (10%) and CCN1
secretion was determined using ELISA as the above. (B) Reduced CCN1 secretion after CSE in the p38 MAPK and JNK siRNA transfected Beas2B cells.
Beas2B cells were transfected with siRNA first. After 24 h, these cells were exposed to CSE (10%). After another 24 h, CCN1 secretion was determined
using ELISA. (C) CSE (10%) induced JNK and p38 MAPK phosphorylation in Beas2B cells, determined by Western Blot analysis. (D) Deletion of Ire-1a by
siRNA reduced CSE triggered CCN1 secretion. Beas2B cells were transfected with Ire-1a siRNA, followed by CSE (10%) exposure. CCN1 secretion was
determined using ELISA as the above. Inset: the efficiency of Ire-1a deletion using siRNA. (E) Beas2B cells were transfected with Ire-1a siRNA or control
siRNA, followed by CSE (10%). After 8 h, cell lysate was subjected to Western Blot analysis. pJNK, total JNK, p-p38 MAPK and total p38 MAPK were
analyzed. (F) Beas2B cells were treated with ER stress inducer, thapsigargin (1 mM). CCN1 release was analyzed using ELISA. To determine the
signaling pathways involved in the ER stress inducer triggered CCN1 release, we pre-treated the cells using a variety of pathway inhibitors as shown,
followed by thapsigargin (1 mM). (G) Similarly, the above samples from (B) were subjected to ELISA to determine CCN1 secretion in p38 MAPK and
JNK siRNA treated Beas2B cells. (H) Blocking of Ire-1a and/or PERK suppressed CCN1 secretion induced by thapsigargin. Beas2B cells were transfected
with control siRNA or Ire-1a siRNA, treated with solvent or PERK inhibitor (10 mM), followed by thapsigargin (1 mM). CCN1 secretion was measured as
above mentioned. *p,.05 All figures above represented two or three independent experiments with similar results.
doi:10.1371/journal.pone.0068199.g004
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were viewed using an Olympus FluoView FV10i confocal laser
scanning microscope.
ROS detection after CSE treatment. Beas2B cells were
stimulated with 10% CSE. After 6 h, cells were detached with
trypsin-EDTA. Next, cells were washed with fresh PBS two times
and ROS was detected using Image-iT TM LIVE Green Reactive
Oxygen Species Detection Kit (Invitrogen, Carlsbad, CA). ROS
level was analyzed using BD FACS Canto II and FlowJo software
(Ashland, OR).
Statistical Analysis (Anova)
The means of fold change in all figures were compared using
two-way analysis of variance to test the differences among
independent samples. With p,0.05, the difference was considered
statistically significant. Error bars indicate the standard deviation.
Results
Cigarette Smoke and Cigarette Smoke Extracts (CSE)
Induced CCN1 Expression in Lung Epithelial Cells
Initially, we found that CCN1 was highly up-regulated in lung
sections obtained from COPD patients (Fig. 1A), comparing with
those from the never-smokers (Gold 0). We next exposed C57/Bl6
mice to CS. After two weeks, the RNA from mice lung tissue was
isolated. Real time PCR showed an elevated CCN1 mRNA
transcription in mice exposed to CS (Fig. 1B). This observation
was confirmed using IHC staining on mice lung tissue (Fig. 1C).
Increased CCN1 expression was found particularly in airway
epithelial cells (red arrow). Lung homogenized tissue from CS
exposed mice also indicated higher CCN1 expression (Fig. S1).
CCN1 Secretion was Augmented by CSE Induced
Reactive Oxygen Spices (ROS) via ER-Golgi and
Aquaporin4 Pathway
CCN1 is a secreted protein and functions in an autocrine or
paracrine manner [20–22]. Therefore, we next determined the
level of secreted CCN1 in epithelial cells. We first characterized
the CCN1 secretion after CSE treatment using Beas2B human
lung epithelial cells. CSE induced CCN1 secretion from Beas2B
cells in dose-dependent manner (Fig. 2A). We confirmed this
observation using the primary lung epithelial cells isolated from
mice. Consistently, 10% or 20% CSE robustly induced CCN1
secretion from primary lung epithelial cells (Fig. 2B). To determine
whether CSE induced CCN1 via triggering oxidative stress, we
first analyzed and confirmed the ROS generation after 10% CSE
in Beas2B cells, using the carboxcy-H2DCFDA methods (Fig. 2C).
Next, we pre-treated Beas2B cells with three different anti-oxidant
reagents (NAC, ascorbic acid and GSH). The CSE induced
secretion of CCN1 in these pre-treated cells was then re-analyzed.
As shown in figure 2D, pretreatment of anti-oxidants abolished
Figure 5. CSE-induced CCN1 release promoted IL-8 secretion from lung epithelial cells. (A) CSE (10%) and ER stress inducer, thapsigargin
(1 mM), triggered IL-8 secretion from Beas2B cells. IL-8 secretion was analyzed using ELISA. (B) Recombinant CCN1-induced IL-8 secretion after 4 h
exposure. (C) Neutralizing antibody anti-CCN1 (mg/ml) reduced CCN1-induced IL-8 secretion in a dose-dependent manner. (D) Deletion of CCN1
suppressed CSE or ER stress inducer thapsigargin induced IL-8 secretion. Beas2B cells were transfected with control siRNA or CCN1siRNA, followed by
CSE (10%) or thapsigargin (1 mM). IL-8 secretion was analyzed using ELISA as above. Inset: the efficiency of CCN1 deletion using siRNA. (E) CCN1 and
thapsigargin (1 mM) (4 h) synergistically enhanced IL-8 secretion in Beas2B cells. *p,.05, ** p,.05 All figures above represented two or three
independent experiments with similar results.
doi:10.1371/journal.pone.0068199.g005
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CSE induced CCN1 secretion. To determine the potential
pathway of CCN1 secretion after CSE, we pre-treated the Beas2B
cells with ER-Golgi inhibitor Brefeldin A (BFA) and a variety of
membrane channel protein inhibitors. Lung epithelial cells
communicate with the adjacent cells or itself via paracrine and/
or autocrine manners. Channel proteins and junction proteins
participate this communication [23]. To investigate the effect of
channel/junction proteins in CCN1 secretion after CSE, we used
a variety of channel/junction protein inhibitors to determine the
major channel/junction protein which plays a role in CCN1
secretion. Therefore, we chose TEA as an aquaporin 1 inhibitor,
a18-GA as a connexin (gap junction) inhibitor, daidzein and 2-BP
as a caveolin inhibitor and TGF-020 as an aquaporin 4 inhibitor.
Pre-treatment of BFA or TGN-020 (aquaporin 4 inhibitor)
partially but significantly decreased the CSE induced CCN1
secretion, as shown in figure 2E and 2F respectively. This result
suggested a potential secretive pathway involving ER-Golgi and
membrane aquaporin 4.
CSE Associated ER Stress Induced CCN1 Secretion in
Lung Epithelial Cells
CSE has been well documented to induce ER stress in a variety
of diseases [24–26]. As shown above, CSE induced CCN1
secretion by epithelial cells involved in the ER-Golgi pathway
(Fig. 2D). In our study, we first determined whether CSE induced
ER stress in lung epithelial cells. After 10% CSE, as soon as 8 h,
BiP/GRP78 was highly induced in Beas2B cells (Fig. 3A). Further,
this CSE induced ER stress was associated with ROS, supported
by the fact that pretreatment of anti-oxidant reagents suppressed
the BiP up-regulation after CSE (Fig. 3B). Blocking BiP expression
by transfection of BiP siRNA significantly suppressed CSE induced
CCN1 secretion (Fig. 3C). To further confirm this observation, we
induced ER stress using chemical inducer thapsigargin. Thapsi-
gargin not only induced ER stress but also induced CCN1
secretion in a dose-dependent manner (Fig. 3D). Consistently,
pretreatment of ER stress inhibitors, tauroursodeoxycholic acid
(TUDCA), 4-phenylbutyric acid (4-PBA) and salubrinal, inhibited
CCN1 secretion after CSE (Fig. 3E). To further confirm our
Figure 6. CSE enhanced IL-8 secretion via LRP6-Wnt pathway. (A) Expression of Wnt signaling associated proteins after CCN1 (1 mg/ml).
Beas2B cells were treated CCN1, after the indicated time, cell lysate was subjected to Western Blot analysis. (B) Translocation of b-catenin from
membrane to cytosol/nucleus after CCN1 (1 mg/ml). White arrow: b-catenin. (C) Wnt signaling inhibitor, XAV, suppressed CCN1 induced IL-8 secretion.
Beas2B cells were treated with XAV at indicated dose (mM), followed by CCN1 recombinant protein (1 mg/ml). After 4 h, IL-8 in supernatant was
determined using ELISA. *p,.05 All figures above represented two or three independent experiments with similar results.
doi:10.1371/journal.pone.0068199.g006
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observation in figure 2 that CCN1 secretion was via membrane
channel aquaporin 4, we pretreated the cells with membrane
channel inhibitors and followed by inducing CCN1 secretion using
ER-stress inducer thapsigargin. CCN1 secretion induced by
thapsigargin was also blocked by TGN-020, aquaporin 4 inhibitor,
suggesting that aquaporin 4 may be a common pathway for CCN1
secretion induced by a variety of stimuli (Fig. 3F).
IRE1-MAPK-JNK Pathway Regulated the CSE Induced
CCN1 Secretion
ER stress has been shown to activate p38 MAPK and JNK [27].
To further investigate the CSE-induced ER stress involved in
CCN1 secretion, we pre-treated Beas2B cells with a variety of
inhibitors including inhibitors for JNK, p38 MAPK, NF-kappaB,
PERK and c-Secretase. After 10% CSE, inhibition of JNK and
p38 MAPK resulted in less CCN1 secretion (Fig. 4A). In addition,
we treated Beas2B cells with p38 MAPK or JNK siRNA, followed
by 10% CSE. Consistently, Beas2B cells treated with p38 MAPK
or JNK siRNA had reduced CCN1 secretion after CSE (Fig. 4B).
Furthermore, CSE induced JNK and p38 MAPK phosphorylation
in Beas2B cells (Fig. 4C). Previous report has shown that activated
IRE1a leads to the phosphorylation of JNK and MAPK pathway
[27]. In our studies, we first evaluated whether IRE1a involved in
CSE induced CCN1 secretion. Deletion of IRE1a using IRE1a
siRNA suppressed CSE induced CCN1 secretion markedly
(Fig. 4D). Further, we confirmed that deletion of IRE1a prohibited
the CSE induced phosphorylation of JNK and p38 MAPK
(Fig. 4E). To determine whether JNK and p38 MAPK pathways
are involved in the ER stress induced CCN1 secretion, we pre-
treated the Beas2B cells with inhibitors to these pathways followed
by ER stress inducer thapsigargin. Cells pretreated with inhibitors
of p38 MAPK or JNK had less CCN1 secretion after ER stress
inducer (Fig. 4F). Similar results were observed when using siRNA
to inhibit p38 MAPK or JNK (Fig. 4G). Additionally, deletion of
IRE1a by IRE1a siRNA also suppressed the ER stress induced
CCN1 secretion (Fig. 4H).
CSE-induced CCN1 Promoted IL-8 Secretion in Lung
Epithelial Cells
CSE highly induced the expression and secretion of CCN1 in
lung epithelial cells, therefore, we next investigated the function of
secreted CCN1 in lung epithelial cells after CS. Lung inflamma-
tion has been well documented after CSE exposure [3] and ER
stress [28]. IL-8 secretion is an important marker in early
inflammation and is crucial for neutrophil recruitments [8].
Initially, we treated epithelial Beas2B cells with CSE and ER stress
Figure 7. CSE-induced CCN1 augments IL-8 secretion. CCN1 was highly up-regulated by CSE, both expression and secretion in lung epithelial
cells. This induction was largely ER stress dependent. Augmented matrix CCN1 next acted on the adjacent epithelial cells in an autocrine or paracrine
manner. CCN1 first phosphorylated Wnt pathway receptor LRP6. Next the Wnt pathway components were increased, such as Dvl2. b-catenin
translocated from cell surface to cytosol and nucleus, subsequently triggered the release of IL-8 from lung epithelial cells.
doi:10.1371/journal.pone.0068199.g007
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inducer thapsigargin. IL-8 secretion was robustly induced by both
CSE and thapsigargin (Fig. 5A). Interestingly, 1 mg/ml recombi-
nant CCN1 (with partial biological activity per manufacture) also
induced IL-8 secretion (Fig. 5B). We further confirmed the CCN1
induced IL-8 secretion by blocking CCN1 using neutralizing
antibody (Fig. 5C). Next, using CCN1 siRNA, we deleted the
endogenous CCN1 in Beas2B epithelial cells (Fig. 5D inset).
Deletion of CCN1 suppressed IL-8 secretion after CSE and ER
stress inducer thapsigargin (Fig. 5D). Moreover, CCN1 and ER
stress inducer thapsigargin synergistically stimulated IL-8 secretion
(Fig. 5E). However, CCN1 and CSE failed to stimulate IL-8
secretion synergistically (Fig. S4).
CCN1 Enhanced Il-8 Secretion via LRP6-Wnt Pathway
To investigate the signal pathways involved in CCN1 triggered
IL-8 secretion, we treated Beas2B cells with CCN1 recombinant
protein in a time-dependent manner. CCN1 significantly induced
Wnt pathway protein Dvl2, receptor LRP6 expression and
phosphorylation (Fig. 6A). After exposed to CCN1 protein, Wnt
pathway component b-catenin translocated from membrane to
cytosol, perinuclear region and nucleus (Fig. 6B), suggesting the
activation of Wnt pathway by CCN1. Pre-treatment of Wnt
pathway inhibitor XAV suppressed the CCN1 induced IL-8
secretion from Beas2B cells (Fig. 6C).
Discussion
Inflammation has been recognized as a central stage for many
CS associated diseases, characterized by increased neutrophils,
lymphocytes, macrophages and pro-inflammatory cytokines/
chemokines [29]. Among all the cytokines and chemokines,
robustly increased IL-8 levels are found in sputum from patients
with COPD [8,30] and particularly at the time of exacerbation
[31,32]. In smokers, the level of IL-8 (both protein and mRNA),
but not other chemokines, is markedly higher comparing with the
control [33–34]. The up-regulation and secretion of IL-8 is
regulated transcriptionally by several transcription factors through
MAPK pathways [35]. However, the mediators between CSE and
IL-8 release have not been completely explored. Our study
identified a novel ECM molecule which regulates the CSE
induced IL-8 secretion. We further illustrated a novel pathway
connecting the initial noxious stimulation (CSE) to the end
effectors (IL-8) in the pathogenesis of lung inflammation. As shown
in figure 7, CCN1, an early stress-response gene product, was
highly up-regulated by CSE, both expression and secretion in lung
epithelial cells. This induction was largely ROS and ER stress
dependent (Fig. 7). Augmented matrix CCN1 next acted on the
adjacent epithelial cells in an autocrine or paracrine manner.
CCN1 first phosphorylated Wnt pathway receptor LRP6. Next
the Wnt pathway components were increased, such as Dvl2. b-
catenin translocated from cell surface to cytosol and nucleus,
subsequently triggered the release of IL-8. This study potentially
suggested a crucial central molecule bridging the noxious stimuli
to the pro-inflammatory chemokines. Furthermore, CCN1, as a
secreted molecule, connected lung epithelial cells to the matrix. By
modulating the release of IL-8, it further provided a cross-talk
between epithelial cells and lung inflammatory cells. CCN1 is
likely a central signal dispatcher controlling the direction of lung
pathogenesis, such as inflammation, apoptosis and fibrosis. In fact,
previous reports have shown important roles of CCN1 in lung
epithelial cell apoptosis after oxidative stress [12]. The findings in
our current report further extended the importance of this ECM
molecule in triggering lung inflammation. Additionally, this study
indicated an important function of lung epithelial cells on the
development of lung inflammation. As a communicator between
lung parenchymal cells and inflammatory cells, as well as a
connector between intracellular components and ECM, CCN1
indicated a potential cellular target for therapy development in a
variety of lung diseases associated with CS.
Our current studies focused on the cellular and molecular
aspects of CCN1 associated IL-8 release. We showed that ROS
and ER stress were highly involved in CSE triggered CCN1 up-
regulation and secretion. It is very possible that other oxidative
stress and ER stress inducers also stimulate CCN1 release, such as
hyperoxia. In fact, this has been hypothesized both in vitro and
in vivo using hyperoxia model [12,13]. CS is a long term (chronic)
process. Continuous and long-lasting stimulation with CS or CSE
may have different effects on CCN1 secretion comparing to acute
stimuli, such as hyperoxia. Our results on the signaling pathways
involved CSE induced CCN1 secretion were based on in-vitro
assays. Chronic CSE or ER stress inducer treatment caused cyto-
toxicity in cultured cells, even at a relatively low dose (Fig. S2, S3).
Thus, the chronic effects of CS on CCN1 release in vivo require
future studies. Our results should not be extrapolated automati-
cally to the animal models chronically exposed to CS, neither to
chronic smokers.
There are also a number of limitations in this current study:
First, the recombinant protein of CCN1 may only carry a partial
bioactivity and thus, we used a relatively larger dose to treat
Beas2B cells in vitro. In reality, the absolute amount of CCN1
protein secreted into ECM largely depends on the number of cells
in the micro-environment. Second, although it induces ER stress,
CSE may function via other alternative signaling pathways. Due to
the complexity of the chemical components in CSE, we are not
able to fully address its signaling pathways besides ER stress, in
current study.
Future directions on the role of CCN1 in CS induced IL-8
release in vivo include the following: 1) Examining the level of
CCN1 and IL-8 using BALF obtained from mice exposed to CS at
different time points; 2) Comparing the time points of CCN1 peak
level and IL-8 peak level; 3) Blocking CCN1 with neutralizing
antibodies in vivo and examining the IL-8 secretion in BALF, in
the presence and absence of CS exposure; 4) Administration of
bioactive CCN1 in vivo and examining the IL-8 secretion in
BALF, in the presence and absence of CS exposure; We
hypothesize that CCN1 release in vivo is associated with acute
exposure of CS (early stress) but will be blunted after chronic
exposure. CCN1 up-regulation in lung tissue after three month
exposure of CS was not as robust as those after the short time
exposure (Fig. S1 and not shown). If this hypothesis is proven true,
clinically, the CCN1 induction could be associated with only acute
inflammation and exacerbation in COPD patients. Therefore,
additionally, future studies also include: 1) to measure CCN1 level
in plasma from mice which are exposed to CSE chronically and
acutely; 2) to determine the probability of CCN1 as a biomarker
for COPD exacerbation.
In summary, CCN1 expression and secretion from lung
epithelial cells are markedly induced by CS and CSE. This
elevated matrix CCN1 plays a crucial role in IL-8 release from
epithelium after CSE exposure.
Supporting Information
Figure S1 CCN1 expression in homogenized lung tissue
from mice exposed to room air or CS. C57/B6J mice (6–8
weeks, male) were exposed to room air or CS as previously
described [18]. After three months, lung tissue was obtained and
homogenized. Lysate was subjected to western blot analysis.
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(TIF)
Figure S2 Dose-dependent effect of CSE on cell viabil-
ity. (A) Beas2B cells were exposed to CSE in different
concentrations. Cell viability was determined after 3, 9 and
24 h. (B) Primary mouse type II lung epithelial cells were treated
with 1, 5 and 10% of CSE, after 24 h, cell viability was
determined.
(TIF)
Figure S3 Dose-dependent effects of ER stress inducer,
thapsigargin, on cell viability. Beas2B cells were treated with
0.1, 0.5 and 1 (mM) of thapsigargin. After 24 h, cell viability was
determined.
(TIF)
Figure S4 CCN1 and CSE have no synergistic effect on
IL-8 secretion. Beas2B cells were treated with CCN1 (1 mg/ml),
CSE (10%) or the combination of these two. IL-8 secretion was
determined using ELISA.
(TIF)
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